1. Home
  2. PPCB

as of 08-14-2026 12:08pm EST

$1.22
$0.00
0.00%
Stocks Nasdaq

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Founded: 2007 Country:
Australia
Australia
Employees: 2 City: CAMBERWELL, VICTORIA
Market Cap: 2.8M IPO Year: 2011
Target Price: N/A AVG Volume (30 days): 137.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.95 EPS Growth: -74150.00
52 Week Low/High: $0.06 - $9.36 Next Earning Date: 05-16-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: -1.28 Index: N/A
Free Cash Flow: -408042.0 FCF Growth: N/A

Share on Social Networks: